OrthoPediatrics Outlines Clinic Expansion, New Products, and Cash Flow Goals

Medical device company details growth plans at Needham Healthcare Conference

Apr. 17, 2026 at 1:06am

Got story updates? Submit your updates here. ›

A minimalist studio still life photograph featuring a collection of polished metal surgical instruments, orthopedic implants, and medical devices arranged in a conceptual display, representing OrthoPediatrics' innovative product pipeline and commitment to advancing pediatric orthopedic care.OrthoPediatrics showcases its expanding portfolio of specialized pediatric orthopedic solutions at the Needham Healthcare Conference.Warsaw Today

Executives from OrthoPediatrics (NASDAQ:KIDS) shared updates on the company's clinic expansion, new product pipeline, and efforts to improve cash flow during a presentation at the 25th Annual Needham Healthcare Conference. The company highlighted plans to grow its Orthotics & Prosthetics Services and Bracing (OPSB) business, launch several new implant systems, and achieve positive free cash flow by 2026.

Why it matters

As a leading provider of pediatric orthopedic solutions, OrthoPediatrics' growth plans and new product introductions are closely watched by investors and the medical community. The company's ability to expand its clinic footprint and generate consistent cash flow will be key to its long-term success.

The details

OrthoPediatrics said it now has over 45 OPSB clinics, up from about 25 at the time of the Boston O&P acquisition, and plans to be in at least 27 of its targeted 80 U.S. territories by the end of 2026. The company noted that locating clinics inside children's hospitals can improve revenue and profitability. On the product side, OrthoPediatrics highlighted upcoming launches including the 3P Hip, VerteGlide, and eLLi systems, as well as continued growth of its 7D navigation technology. Management also discussed efforts to improve cash flow, including reducing set deployments and transitioning its Latin America business to direct sales.

  • In the fourth quarter of 2025, OrthoPediatrics achieved positive free cash flow.
  • The company expects to deploy about $10 million in sets in 2026, down from $17 million in 2025 and $20 million the prior year.
  • OrthoPediatrics plans to launch the 3P Hip system in the summer of 2026 with a broader rollout in the second half of the year.

The players

Fred Hite

CFO and COO of OrthoPediatrics.

OrthoPediatrics

A medical device company dedicated exclusively to providing orthopedic solutions for children, headquartered in Warsaw, Indiana.

Boston O&P

A company acquired by OrthoPediatrics that had about 25 clinics at the time of the acquisition, primarily in the Northeast.

Got photos? Submit your photos here. ›

What they’re saying

“Rather than focusing on a clinic count, management emphasized its longer-term plan to scale into approximately 80 U.S. territories covering roughly 300 children's hospitals.”

— Fred Hite, CFO and COO

“We have learned that locating clinics inside children's hospitals—rather than starting with satellites—can improve revenue and profitability.”

— Fred Hite, CFO and COO

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

OrthoPediatrics' focus on expanding its clinic footprint, launching new innovative products, and improving cash flow positions the company for continued growth in the pediatric orthopedics market. The company's ability to execute on these strategic priorities will be crucial as it seeks to solidify its leadership position.